Skip to main content
. 2021 Jan 16;22(2):852. doi: 10.3390/ijms22020852

Figure 1.

Figure 1

Chemical structures of ritonavir (A), a highly potent CYP3A4 inhibitor in clinical use, and the best two rationally designed inhibitors from series IV [10] (B,C). The R1 and R2 side-groups are indicated. If the central hydroxyl group of ritonavir is removed, the phenyl side-groups would be in R/R configuration.